Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1837

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 8
Chunk 1837
---
,504) 
    $(5,801,354)

The
accompanying notes are an integral part of these financial statements

F-5

JUPITER
NEUROSCIENCES, INC.

STATEMENTS OF CASH FLOWS

    December
                                            31, 2024  
    December
                                            31 2023 
  
    Cash
    Flows from Operating Activities: 

    Net
    Loss 
    $(2,439,625) 
    $(4,783,689)
  
    Adjustments
    to reconcile net loss to net cash used in operating activities: 

    Loss
    (Gain) on change in fair value of derivative liability 
     53,257  
     (148,751)
  
    Amortization
    of debt discounts 
     43,288  
     16,712 
  
    (Gain)
    Loss on extinguishment of debt 
     (857,723) 
     887,946 
  
    Gain
    on forgiveness of accrued compensation 
     (40,000) 
     - 
  
    Amortization of prepaid contracts 
     54,612  
     - 
  
    Stock-based compensation 
     1,840,908  
     1,198,579 
  
    Changes
    in operating assets and liabilities: 

    Decrease (increase) in prepaid contracts 
     (2,300,000) 
     - 
  
    Decrease
    (increase) in prepaid and other current assets 
     (113,826) 
     4,971 
  
    Increase
    (Decrease) in operating lease right of use asset 
     (1,785) 
     25 
  
    Increase
    (Decrease) in accounts payable and accrued expenses 
     (149,530) 
     164,881 
  
    Increase
    (Decrease) in accrued compensation 
     (46,948) 
     2,140,103 
  
    Increase
    in accrued interest 
     46,368  
     38,270 
  
    Net
    cash used in operating activities 
     (3,911,004) 
     (480,953)

    Cash
    Flows from Financing Activities: 

    Proceeds
    from note payable, related parties 
     138,500